Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci

Flávia C. Leonardo*, Ana F. Brugnerotto, Igor F. Domingos, Kleber Y. Fertrin, Dulcinéia M. de Albuquerque, Marcos A C Bezerra, Aderson S. Araújo, Sara T O Saad, Fernando F. Costa, Stephan Menzel, Nicola Conran, Swee Lay Thein

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    26 Citations (Scopus)

    Abstract

    The presence of high levels of fetal haemoglobin (HbF) provides well-validated clinical benefits to patients with sickle cell anaemia (SCA). Nevertheless it has been difficult to show clear direct effects of the known genetic HbF modifiers, such as the enhancer polymorphisms for haematopoietic transcription factors BCL11A and MYB, on SCA severity. Investigating SCA patients from Brazil, with a high degree of European genetic admixture, we have detected strong effects of these variants on HbF levels. Critically, we have shown, for the first time, that the presence of such HbF-promoting variants leads to a reduced rate of SCA complications, especially stroke.

    Original languageEnglish
    Pages (from-to)456-460
    Number of pages5
    JournalBritish Journal of Haematology
    Volume173
    Issue number3
    DOIs
    Publication statusPublished - May 2016

    Keywords

    • BCL11A
    • HbF quantitative trait loci
    • HMIP-2

    Fingerprint

    Dive into the research topics of 'Reduced rate of sickle-related complications in Brazilian patients carrying HbF-promoting alleles at the BCL11A and HMIP-2 loci'. Together they form a unique fingerprint.

    Cite this